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FlavonolAbstract On continuation of the phytochemical investigation of the MeOH extract of Cyperus
rotundus L. Rhizomes, four compounds namely, methyl 3,4-dihydroxy benzoate (1), ipolamiide
(2), 6b-hydroxyipolamiide (3), and rutin (4) were isolated. Their structures were established on
the basis of 1D and 2D NMR spectroscopic analyses as well as ESIMS spectral data. Compounds
2 and 3 are reported here for the ﬁrst time from the genus Cyperus and 1 for the ﬁrst time from the
plant. Co-treatment of CCl4 hepatic injured rats with the total MeOH extract (TME) and EtOAc
fraction signiﬁcantly restored the hepatic marker enzymes and total bilirubin to near-normal values
compared to silymarin (reference drug).
ª 2015 Production and hosting by Elsevier B.V. on behalf of Faculty of Pharmacy, Cairo University.1. Introduction
Cyperus rotundus L. (Nutgrass, family Cyperaceae) is widely
distributed in many tropical and subtropical regions of the
world.1 In the Egyptian folk medicine, its tubers are used as
anthelmintic, aphrodisiac, diuretic, sedative, carminative, stim-
ulant, tonic, and stomachic.1 Also, they are used as a remedy
for renal colic and dysentery.2 Furthermore, the plant pos-
sesses different biological activities such as antioxidant,3–5
cytotoxic,3,5 anti-allergic,6,7 antipyretic, anti-inﬂammatory,
antiemetic, hypotensive,8 anticonvulsant,9 anti-malarial,
antimicrobial,10,11 anti-diarrhoeal,12 anti-diabetic,5,13,14
hepatoprotective,14,15 and insecticide.16,17 The previous phyto-
chemical studies of C. rotundus L. led to the isolation of sesqui-
terpenes,13,18–23 ﬂavonoids,3,5,8,24,25 phenylpropanoids,5,26,27phenolic acids,5,26 alkaloids,28 and saponins.29 In 2013 Zhou
and Zhang reported the isolation of iridoid glycosides from
C. rotundus rhizomes.27 This prompted further investigation
of the EtOAc fraction of the MeOH extract of C. rotundus
rhizomes aiming to isolate iridoids. The present work reports
the isolation and identiﬁcation of methyl 3,4-dihydroxy benzo-
ate (1), ipolamiide (2), 6b-hydroxyipolamiide (3), and rutin (4)
(Fig. 1). TME and EtOAc fraction were tested for their hepa-
toprotective activity against CCl4-induced hepatic injury.
2. Experimental
2.1. General procedures
The ESIMS spectra were recorded on a Finnigan MATTSQ-
7000 triple stage quadrupole mass spectrometer (Thermo Finn-
igan, Bremen, Germany). 1D and 2D NMR spectra (chemical
shifts in ppm, coupling constants in Hz) were recorded on a
Bruker DRX400 NMR spectrometer using CD3OD and
Figure 1 Structures of the isolated compounds 1–4.
6 G.A. MohamedDMSO-d6 as solvents, with TMS as the internal reference
(Bruker, Rheinstetten, Germany). Solvents were distilled prior
to use and spectral grade solvents were used for spectroscopic
measurements. Column chromatographic separations were
performed on silica gel 60 (0.04–0.063 mm, Merck, Darmstadt,
Germany). TLC was performed on precoated TLC plates with
silica gel 60 F254 (layer thickness 0.2 mm, Merck). The com-
pounds were detected by spraying with p-anisaldehyde/
H2SO4 reagent and heating at 110 C for 1–2 min. Silymarin
was purchased from Sigma–Aldrich chemical Co. (St. Louis,
MO, USA).
2.2. Plant material
The rhizomes of C. rotundus L. were collected in June 2009
from plants growing in the campus of Al-Azhar University,
Assiut Branch, Egypt. The plant was kindly identiﬁed by Salah
El-Nagar, Professor of Plant Taxonomy, Faculty of Science,
Assiut University, Assiut, Egypt. A voucher sample (2009-
CR110) was kept in the Herbarium of the Pharmacognosy
Department, Faculty of Pharmacy, Al-Azhar University,
Assiut, Egypt.
2.3. Extraction and isolation
The fresh rhizomes (1.2 kg) were cut and defatted using n-hex-
ane (3 · 2 L), then extracted with MeOH (4 · 2 L). The MeOH
extract was evaporated and concentrated under reduced pres-
sure to afford a dark brown residue (14.1 g). The latter was
subjected to VLC (vacuum liquid chromatography) usingn-hexane/EtOAc and EtOAc/MeOH gradients to afford ﬁve
fractions: CR-I to CR-V: CR-I (2.3 g, n-hexane/EtOAc
75:25%), CR-II (1.9 g, n-hexane/EtOAc 50:50%), CR-III
(2.1 g, n-hexane/EtOAc 25:75%), CR-IV (1.8 g, EtOAc
100%), and CR-V (5.2 g, MeOH 100%). The fraction CR-IV
(1.8 g) was subjected to silica gel column chromatography
(80 g · 50 · 2 cm) using CHCl3/MeOH gradient to give ﬁve
major sub-fractions CR-IV-A to CR-IV-E. Silica gel column
chromatography (80 g · 50 · 2 cm) of sub-fraction CR-IV-B
(175 mg) using n-CHCl3/MeOH as an eluent gave compound
1 (11 mg, brown residue). Sub-fraction CR-IV-C (195 mg)
was chromatographed over silica gel column
(80 g · 50 · 2 cm) using CHCl3/MeOH gradient to obtain 2
(4.3 mg, white amorphous powder). Sub-fraction CR-IV-D
(411 mg) was chromatographed on silica gel column using
CHCl3/MeOH gradient to afford 3 (5.1 mg, white amorphous
powder). Silica gel column chromatography
(100 g · 50 · 2 cm) of sub-fraction CR-IV-E (350 mg) using
CHCl3/MeOH as an eluent gave 4 (18 mg, yellow amorphous
powder).
Methyl-3,4-dihydroxy benzoate (1): It was isolated as a
brown residue (11 mg). ESIMS: m/z 169 [M+H]+. 1H NMR
(DMSO-d6, 400 MHz): dH 7.42 (1H, d, J = 2.2 Hz, H-2),
6.84 (1H, d, J = 7.6 Hz, H-5), 7.45 (1H, dd, J = 7.6, 2.2 Hz,
H-6), 12.56 (1H, s, 3-OH), 9.88 (1H, s, 4-OH). 13C NMR
(DMSO-d6, 100 MHz): dC 121.6 (s, C-1), 112.7 (d, C-2),
147.2 (s, C-3), 151.1 (s, C-4), 115.0 (d, C-5), 123.5 (d, C-6),
167.2 (s, C-7), 55.5 (q, 7-OCH3).
30
Rutin (4): It was isolated as a yellow amorphous powder
(18 mg). ESIMS: m/z 611 [M+H]+. 1H NMR (CD3OD,
400 MHz): dH 6.19 (1H, d, J = 1.8 Hz, H-6), 6.38 (1H, d,
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J = 6.8 Hz, H-50), 7.61 (1H, dd, J = 6.8, 1.8 Hz, H-60), 5.11
(1H, d, J = 7.4 Hz, H-100), 4.51 (1H, d, J = 0.6 Hz, H-100 0),
1.11 (3H, d, J = 6.0 Hz, H-600 0), 3.28–3.81 (m, other sugar pro-
tons). 13C NMR (CD3OD, 100 MHz): dC 157.2 (s, C-2), 133.9
(s, C-3), 177.9 (s, C-4), 161.5 (s, C-5), 98.8 (d, C-6), 166.1 (s, C-
7), 92.7 (d, C-8), 156.5 (s, C-9), 105.0 (s, C-10), 121.8 (s, C-10),
115.3 (d, C-20), 145.2 (s, C-30), 148.5 (s, C-40), 116.3 (d, C-50),
121.7 (d, C-60), 101.2 (d, C-100), 74.1 (d, C-200), 76.0 (d, C-300),
70.1 (d, C-400), 76.5 (d, C-500), 67.1 (d, C-600), 100.8 (d, C-100 0),
70.4 (d, C-200 0), 70.6 (d, C-300 0), 71.9 (d, C-400 0), 68.3 (d, C-500 0),
17.3 (q, C-600 0).8,31
2.4. Pharmacological study
2.4.1. Animals
Adult male albino rats weighing 120–150 g were obtained from
the animal facility of Faculty of Pharmacy, King Saud Univer-
sity, Riyadh, KSA. Animals were housed at a temperature of
23 ± 2 C with free access to water and standard food pellets.
Rats were left to acclimatize in the animal facility for 1 week
prior to experimentation. All animal procedures were con-
ducted in accordance with the guidelines of the Institutional
Animal Ethics Committee of King Saud University (approval
number KSU/IAEC/1432/12).
2.4.2. Hepatoprotective activity
The hepatoprotective activity was determined as previously
outlined.32 Rats were randomly divided into ﬁve groups of 6
animals each. The 1st group was given olive oil in an oral dose
of 1 mL/kg of body weight (b.wt) for 5 successive days and
kept as a negative control. Animals of the 2nd group were
given a single oral dose of 50% CCl4 in olive oil (1 mL/kg
b.wt) (positive control). The 3rd group was treated daily with
25 mg/kg b.wt silymarin (a standard drug) for 5 successive
days. The 4th and 5th groups were orally administeredTable 1 NMR data of compound 2 and 3 (CD3OD, 400 and 100 M
No. 2
dH [mult., J (Hz)] dC (mult.) HMBC
1 5.80 brs 93.2 (CH) 10, 3, 5, 8
3 7.43 s 152.1 (CH) 1, 4, 11
4 – 114.8 (C) –
5 – 71.0 (C) –
6 2.25 m 38.1 (CH2) 4, 5, 7, 8
2.08 m 4, 6
7 1.93 m 39.7 (CH2) 5, 6, 8
1.56 m 5, 6, 8, 9
8 – 77.4 (C)
9 2.45 s 60.5 (CH) 1, 4, 5, 8
10 1.14 s 22.1 (CH3) 7, 8, 9
11 – 166.8 (C) –
10 4.57 d (7.4) 99.7 (CH) 1, 30
20 3.65 m 72.8 (CH) –
30 3.36 m 77.0 (CH) 20, 40
40 3.31 m 70.1 (CH) 60
50 3.36 m 76.3 (CH) 20, 40
60 3.16 m 61.8 (CH2) 10, 30
3.23 m
11-OCH3 3.87 s 51.7 (CH3) 11100 mg/kg b.wt of the TME and EtOAc fraction, respectively,
for 5 successive days. Twenty-four hours following the last
dose, rats of the 3rd–5th groups were given a single dose of
50% CCl4 in olive oil (1 mL/kg b.wt, orally). Two days later,
blood samples were obtained from the orbital plexus of each
rat. The serum was obtained by centrifugation at 3000 rpm
for 15 min and serum samples were taken for biochemical
assays, namely glutamate oxaloacetate transaminase (SGOT),
glutamate pyruvate transaminase (SGPT), and Total bilirubin
(TB).
2.4.3. Statistical analysis
The data were expressed as mean SE (n= 6). Results were
analyzed statistically by one-way ANOVA followed by com-
parison using Prism software (Graph Pad. Ver. 3.0).
3. Results and discussion
Compound 2 was obtained as a white amorphous powder. It
had a molecular formula C17H26O11, which was determined
by ESIMS pseudo-molecular ion peak at m/z 407 [M+H]+.
The 13C NMR spectrum of 2 (Table 1) showed 17 carbon sig-
nals, six of which could be assigned to b-glucopyranosyl moi-
ety33 and one for one methoxy group. Their multiplicities were
determined by HMQC experiment. The NMR spectra of 2
(Table 1) exhibited the characteristic signals for an iridoid
structure and showed the existence of a methoxy carbonyl
function (dH 3.87, s)/dC 51.7 (11-OCH3) and 166.8 (C-11),
and a tertiary methyl group (dH 1.14, s, H3-10)/dC 22.1 (C-
10).34,35 In addition, resonances arising from two methylene
groups were observed at dH 2.25 (m, H-6A) and 2.08 (m, H-
6B)/dC 38.1 (C-6), 1.93 (m, H-7A) and 1.56 (m, H-7B)/dC
39.7 (C-7). In addition to, three singlet signals at dH 5.80,
7.43, and 2.45 were attributed to H-1, H-3, and H-9, respec-
tively. They correlated with the carbons resonating at dC
93.2 (C-1), 152.1 (C-3), and 60.5 (C-9) in the HMQC spectrum.Hz).
3
dH [mult., J (Hz)] dC (mult.) HMBC
5.83 brs 93.5 (CH) 10, 3, 5, 6
7.48 s 153.1 (CH) 1, 4, 5, 11
– 113.8 (C) –
– 70.1 (C) –
4.03 dd (6.8, 5.1) 75.8 (CH) 4, 8, 9
1.98 m 47.5 (CH2) 1, 5, 6, 9
, 10 1.87 m
– 78.2 (C)
, 10 2.55 s 60.2 (CH) 1, 4, 5, 6
1.12 s 23.2 (CH3) 6, 7, 8, 9
– 167.0 (C) –
4.57 d (7.6) 99.8 (CH) 1, 30
3.72 m 73.0(CH) –
3.39 m 77.5 (CH) 20, 40
3.34 m 70.2 (CH) 60
3.41 m 76.5 (CH) 20, 40
3.19 m 62.5 (CH2) 1
0, 30
3.22 m
3.72 s 51.6 (CH3) 11
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the anomeric proton of b-glucopyranose unit.33 It correlated
with the anomeric carbon resonating at dC 99.7 (C-1) in the
HMQC spectrum. The downﬁeld shift of the H-1 signal (dH
5.80), indicated the attachment of the-glucopyranose unit at
the C-1 position of the iridoid aglycone. This was conﬁrmed
by the HMBC cross peaks observed between H-1 at dH 5.80
and anomeric carbon of glucose moiety C-10 at dC 99.7, and
H-10 at dH 4.57 and C-1 (dH 93.2) (Fig. 2). The methoxy car-
bonyl group was assigned to be positioned at C-4 due to the
highly deshielded signal of the H-3. Also, it was secured by
the HMBC cross peak between methoxy group at dH 3.87
and C-11 (dC 166.8) and H-3 and C-11. The multiplicity of
H-9 was also indicative of a totally substituted C-8. However,
the HMBC cross peaks of the tertiary methyl group (dH 1.14,
s) to C-7, C-8 and C-9, suggested its attachment at C-8. By the
complete analysis of the NMR data of 2 and comparison of
these data with those given in the literature,34–37 compound
2 was determined to be ipolamiide, which is reported here
for the ﬁrst time from genus Cyperus.
Compound 3 was isolated as a white amorphous powder
and showed a ESIMS pseudo-molecular ion peak at m/z 423
[M+H]+, which conﬁrmed the molecular formula
C17H26O12. Compound 3 is 16 mass units more than 2, indicat-
ing the presence of an additional hydroxyl group. The NMRFigure 2 Key HMBC correlations of compounds 2 and 3.
Table 2 Effect of TME and EtOAc fraction on the level of liver en
Animal group SGOT (IU/L)
Control (Negative control) 21.17 ± 0.940
CCl4 treated (Positive control) 62.92 ± 2.790
a
Silymarin + CCl4 24.81 ± 1.650
a,b
TME+ CCl4 39.17 ± 2.940
a,b,c
EtOAc fraction + CCl4 32.53 ± 2.910
a,b,c
S.E. = Standard error; n= 6.
a Signiﬁcant from control at P< 0.05.
b Signiﬁcant from CCl4 at P< 0.05.
c Signiﬁcant from silymarin at P< 0.05.data for 2 and 3 were quite similar (Table 1), but the signals
associated with the methylene group at dH 2.25 and 2.08
(H2-6)/dC 38.1 (C-6) found in 2 were not observed in the spec-
tra for 3. Instead, a new signal for oxymethine at dH 4.03 (1H,
dd, J= 6.8, 5.1 Hz, H-6) was observed and correlated to car-
bon signal at dC 75.8 (C-6) in the HMQC spectrum and
showed HMBC correlations to C-4, C-8, and C-9 conﬁrming
its position (Fig. 2). On the basis of these ﬁndings and by com-
parison of the literature data together with those obtained
from NMR spectra,34–37 the structure of 3 was unambiguously
elucidated and determined to be 6b-hydroxyipolamiide and
reported here for the ﬁrst time from genus Cyperus.
Other compounds were identiﬁed as methyl 3,4-dihydroxy
benzoate (1)30 and rutin (4)8,31 by analysis of the spectroscopic
data and comparison of their data with those in the literature.
C. rotundus is known to be a rich source of ﬂavonoids and
phenolic compounds of various biological activities.3,5,8 Oral
CCl4 administration caused liver injury in rats that was mani-
fested by signiﬁcant elevation in the levels of serum hepatic
marker enzymes (SGOT and SGPT) and total bilirubin (TB)
as shown in Table 2. The results revealed a marked elevation
in enzyme activities of group 2 (CCl4-administered rats) when
compared with group 1 (control rats). In comparison with the
CCl4-treated group, signiﬁcant improvements were seen in the
serum activity of SGOT, SGPT, and total bilirubin in rats that
had been previously medicated with silymarin, TME, and
EtOAc fraction (Table 2). The biochemical mechanism of
CCl4 toxicity is based on mitochondrial damage that leads to
an accumulation of fat within 60 min, damage of endoplasmic
reticulum within 30 min, and damage of lysosomes, which
result in death of the hepatocytes.38,39 The observed hepato-
protective effect of C. rotundus against CCl4-hepatotoxicity is
attributed to the presence of ﬂavonoids, which are known to
be hepatoprotective and antioxidants that act as free radical
scavengers for the lipoperoxidants.40 The hepatoprotective
effect of the TME seems to involve the maintaining of the liver
antioxidative defense systems in addition to the scavenging of
reactive oxygen species (ROS) and NO; these lead to an inhi-
bition of lipid peroxidation.41
4. Conclusions
Re-investigation of the MeOH extract of C. rotundus rhizomes
afforded four compounds. Compound 1 is reported for the
ﬁrst time from C. rotundus. While, 2 and 3 were isolated for
the ﬁrst time from genus Cyperus. Their structures were estab-
lished by different spectroscopic analyses. The TME and
EtOAc fraction showed signiﬁcant hepatoprotective activity.zymes in CCl4 treated rats.
SGPT (IU/L) TB (mg/dL)
34.76 ± 0.430 0.57 ± 0.050
45.99 ± 2.910a 1.82 ± 0.207a
31.13 ± 2.110a,b 0.69 ± 0.029a,b
36.79 ± 1.810a,b,c 1.12 ± 0.321a,b,c
34.94 ± 1.490a,b,c 0.91 ± 0.130a,b,c
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None.
References
1. Boulos L, El-Hadidi MN. The weed ﬂora of Egypt. Cairo: The
American University in Cairo Press; 1984, 58.
2. Boulos L. Medicinal plants of North Africa. Algonac: Reference
Publications; 1983, 82.
3. Sayed HM, Mohamed MH, Farag SF, Mohamed GA, Proksch P.
A new steroid glycoside and furochromones from Cyperus
rotundus L. Nat Prod Res 2007;21:343–50.
4. Nagulendran K, Velavan S, Mahesh R, Begum VH. In vitro
antioxidant activity and total polyphenolic content of Cyperus
rotundus rhizomes. E-J Chem 2007;4:440–9.
5. Sayed HM, Mohamed MH, Farag SF, Mohamed GA, Omobu-
wajo ORM, et al. Fructose-amino acid conjugate and other
constituents from Cyperus rotundus L. Nat Prod Res
2008;22:1487–97.
6. Meena AK, Yadav AK, Niranjan US, Singh B, Nagariya AK,
et al. Review on Cyperus rotundus – a potential herb. Int J Pharm
Clin Res 2010;2:20–2.
7. Jin JH, Lee DU, Kim YS, Kim HP. Anti-allergic activity of
sesquiterpenes from the rhizomes of Cyperus rotundus. Arch
Pharm Res 2011;34:223–8.
8. Sayed HM, Mohamed MH, Farag SF, Mohamed GA. Phyto-
chemical and biological investigations of Cyperus rotundus L. Bull
Fac Pharm Cairo Univ 2001;39:195–203.
9. Mayur P, Pawan P, Ashwin S, Pravesh S. Evaluation of
anticonvulsant activity of roots and rhizomes of Cyperus rotundus
Linn. in mice. Int Res J Pharm 2011;2:37–41.
10. Thebtaranonth C, Thebtaranonth Y, Wanauppathamkul S,
Yuthavong Y. Antimalarial sesquiterpenes from tubers of Cyperus
rotundus: structure of 10,12-peroxycalamenene, a sesquiterpene
endoperoxide. Phytochemistry 1995;40:125–8.
11. Ahmad M, Mahayrookh, Mehjabeen, Rehman AB, Jahan N.
Analgesic, antimicrobial and cytotoxic effect of Cyperus rotundus
ethanol extract. Pakistan J Pharmacol 2012;29:7–13.
12. Daswani PG, Brijesh S, Tetali P, Birdi TJ. Studies on the activity
of Cyperus rotundus Linn. tubers against infectious diarrhea.
Indian J Pharmacol 2011;43:340–4.
13. Bawden K, Quant J, Raman A. An alpha-amylase assay for the
guided fractionation of anti-diabetic plants. Fitoterapia
2002;2:167.
14. Sivapalan SR. Medicinal uses and pharmacological activities of
Cyperus rotundus Linn. – a review. Int J Sci Res Pub
2013;3:1–8.
15. Mehta RS, Shankar MB, Geetha M, Saluja AK. Evaluation of
Cyperus rotundus for hepatoprotective activity. Indian J Nat Prod
1999;15:13–7.
16. Morimoto M, Fuji Y, Komai K. Antifeedants in Cyperaceae:
coumaran and quinines from Cyperus spp. Phytochemistry
1999;51:605–8.
17. Singh N, Pandey BR, Verma P, Bhalla M, Gilca M. Phyto-
pharmacotherapeutics of Cyperus rotundus Linn. (Motha): an
overview. Indian J Nat Prod Res 2012;3:467–76.
18. Sonwa MM, Ko¨nig WA. Chemical study of the Cyperus rotundus.
Phytochemistry 2001;58:799–810.
19. Ha JH, Lee KY, Choi HC, Cho J, Kang BS, et al. Modulation of
radioligand binding to the GABA(A)-benzodiazepine receptor
complex by a new component from Cyperus rotundus. Biol Pharm
Bull 2002;25:128–30.
20. El-Gohary HMA. Study of essential oils of the tubers of Cyperus
rotundus L. and Cyperus alopecuroides Rottb. Bull Fac Pharm
Cairo Univ 2004;42:157–64.21. Xu Y, Zhang H, Yu C, Lu Y, Chang Y, et al. Norcyperone, a
novel skeleton norsesquiterpene from Cyperus rotundus L. Mole-
cules 2008;13:2474–81.
22. Lawal OA, Oyedeji AO. Chemical composition of the essential oils
of Cyperus rotundus L. from South Africa. Molecules
2009;14:2909–17.
23. Kim SJ, Ryu B, Kim HY, Yang YI, Ham J, et al. Sesquiterpenes
from the rhizomes of Cyperus rotundus and their potential to
inhibit LPS-induced nitric oxide production. Bull Korean Chem
Soc 2013;34:2207–10.
24. El-Habashy L, Mansour RMA, Zahran MA, El-Hadidi MN,
Saleh NAM. Leaf ﬂavonoids of Cyperus species in Egypt. Biochem
Syst Ecol 1989;17:191–5.
25. Krishna S, Renu S. Isolation and identiﬁcation of ﬂavonoids from
Cyperus rotundus Linn. in vivo and in vitro. J Drug Delivery Ther
2013;3:109–13.
26. Koichiro K, Kunikazu U. Secondary metabolic compounds in
purple nutsedge (Cyperus rotundus L.) and their plant growth
inhibition. Shokubutsu no Kagaku Chosetsu 1981;16:32–7.
27. Zhou Z, Zhang H. Phenolic and iridoid glycosides from the
rhizomes of Cyperus rotundus L. Med Chem Res 2013;22:4830–5.
28. Jeong S, Miyamoto T, Inagaki M, Kim Y, Higuchi R. Rotundines
A–C, three novel sesquiterpene alkaloids from Cyperus rotundus. J
Nat Prod 2000;63:673–5.
29. Singh PN, Singh SB. A new saponin from mature tubers of
Cyperus rotundus. Phytochemistry 1980;19:2056.
30. Gerothanassis IP, Exarchou V, Lagouri V, Troganis A, Tsimidou
M, et al. Methodology for identiﬁcation of phenolic acids in
complex phenolic mixtures by high-resolution two-dimensional
nuclear magnetic resonance. Application to methanolic extracts of
two oregano species. J Agric Food Chem 1998;46:4185–92.
31. Agrawal PK. Carbon-13 NMR of ﬂavonoids. New York,
Tokyo: Elsevier Science; 1989.
32. Mohamed GA, Ibrahim SRM, Elkhayat ES, Ross SA, Sayed HM,
et al. Blepharisides A and B, new ﬂavonol glycosides from
Blepharis ciliaris growing in Saudi Arabia. Phytochemistry Lett
2015;11:177–82.
33. Agrawal PK. NMR spectroscopy in the structural elucidation of
oligosaccharides and glycosides. Phytochemistry 1992;31:3307–30.
34. Erso¨z T, Harput U¨S, Calis I`, Donmez AA. Iridoid, phenyletha-
noid and monoterpene glycosides from Phlomis sieheana. Turk J
Chem 2002;26:1–8.
35. Gu¨venalp Z, O¨zbek H, U¨nsalar T, Kazaz C, Demirezer LO¨.
Iridoid, ﬂavonoid, and phenylethanoid glycosides from Wied-
emannia orientalis. Turk J Chem 2006;30:391–400.
36. Dinda B, Debnath S, Harigaya Y. Naturally occurring iridoids. A
Review, Part 1. Chem Pharm Bull 2007;55:159–222.
37. Dinda B, Roychowdhury D, Mohanta BC. Naturally occurring
iridoids, secoiridoids and their bioactivity. An updated review,
Part 3. Chem Pharm Bull 2009;57:765–96.
38. Rathi A, Srivastava AK, Shirwaikar A, Rawat AKS, Mehrotra S.
Hepatoprotective potential of Fumaria indica Pugsley whole plant
extracts, fractions and an isolated alkaloid protopine. Phytomed-
icine 2008;15:470–7.
39. Leitron P, Labbe G, Degorr C, Berson A, Fromenty B, et al.
Mechanism for the protective effects of silymarin against carbon
tetrachloride induced lipid peroxidation and hepatotoxicity in
mice. Evidence that silymarin acts both as an inhibitor of
metabolic activation and as a chain-breaking antioxidant. Biochem
Pharmacol 1990;39:2027–34.
40. Sintayehu B, Bucar F, Veeresham C, Asres K. Hepatoprotective
and free radical scavenging activities of extracts and a major
compound isolated from the leaves of Cineraria abyssinica Sch.
Bip. exA. Rich. Phcog J 2012;4:40–6.
41. Garcı´a-Lafuente A, Guillamo´n E, Villares A, Rostagno MA,
Martı´nez JA. Flavonoids as anti-inﬂammatory agents: implications
in cancer and cardiovascular disease. Inﬂamm Res 2009;58:537–52.
